Article in "transkript": 10 minutes make all the difference

The First 10 Minutes: Why rapid tissue sample processing is essential for understanding the molecular reality of cancer

Developing effective therapies for increasingly specific patient cohorts is the core aim of precision oncology. Despite medical advancements, many new drugs fail during development due to the lack of therapeutic targets identified early for specific tumor types. The integrity of underlying tumor samples is key. Research shows that limiting ischemia time to under 10-12 minutes significantly impacts target detectability.

Our CEO and Founder Hartmut Juhl discusses in this article how optimized tumor collection processes and high-quality multi-omics data can enhance the identification of novel, disease-relevant targets, ultimately increasing the success rates of preclinical and clinical research.

Read the full article in German